Local antifungal immunity in the kidney in disseminated candidiasis

Curr Opin Microbiol. 2021 Aug:62:1-7. doi: 10.1016/j.mib.2021.04.005. Epub 2021 May 12.

Abstract

Disseminated candidiasis is a hospital-acquired infection that results in high degree of mortality despite antifungal treatment. Autopsy studies revealed that kidneys are the major target organs in disseminated candidiasis and death due to kidney damage is a frequent outcome in these patients. Thus, the need for effective therapeutic strategies to mitigate kidney damage in disseminated candidiasis is compelling. Recent studies have highlighted the essential contribution of kidney-specific immune response in host defense against systemic infection. Crosstalk between kidney-resident and infiltrating immune cells aid in the clearance of fungi and prevent tissue damage in disseminated candidiasis. In this review, we provide our recent understanding on antifungal immunity in the kidney with an emphasis on IL-17-mediated renal defense in disseminated candidiasis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antifungal Agents* / therapeutic use
  • Candida albicans
  • Candidiasis*
  • Humans
  • Kidney

Substances

  • Antifungal Agents